LAG3 Peptide

• NCBI Gene ID:

  3902

• Swiss Prot:

  P18627

• Accession Number:

  NP_002277

• Type:

  Peptides

• Concentration:

  200 ug/mL

• Buffer:

  PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  Store LAG3 peptide at -20˚ C, stable for one year.

• Applications Notes:

  LAG3 peptide is used for blocking the activity of LAG3 antibody.

• NCBI Official Name:

  Lymphocyte activating 3

• NCBI Organism:

  Homo sapiens

• Background Reference 01:

  Huard B, Tournier M, Hercend T, et al. Lymphocyte-activation gene 3/major histocompatibility complex class II interaction modulates the antigenic response of CD4+ T lymphocytes. Eur J Immunol 1994; 24:3216–21.

• Background Reference 02:

  Triebel F. LAG-3: a regulator of T-cell and DC responses and its use in therapeutic vaccination. Trends Immunol 2003; 24:619–22.

• Background Reference 03:

  Workman CJ, Wang Y, El Kasmi KC, et al. LAG-3 regulates plasmacytoid dendritic cell homeostasis. J Immunol. 2009; 182:1885–91.

• Background Reference 04:

  Workman CJ, Vignali DA. The CD4-related molecule, LAG-3 (CD223), regulates the expansion of activated T cells. Eur J Immunol 2003; 33:970–9.

• Other Product Names:

  Lymphocyte activating 3, LAG-3, CD223

• Tested Applications:

  Blocking

• Species:

  Human

• Protein ID:

  167614500

• Physical Properties:

  Liquid